|
|
|
Back to: Home
» Medicine Cabinet
» Others
|
 |
|
|
|
|
|
Luveris (Lutropin Alfa)
|
|
No Prescription is required for this product |
| Product Size |
Retail Price |
Our Price |
|
| Brand 75IU 1 vial(s) |
$62.40 |
$48.00 |
 |
|
For multiple quantities , edit your quantity when you click on checkout or click BUY until you reach your required amount. |
|
|
|
Manufacturer:
No Manufacturer Listed
|
Description
Luveris is the first and only recombinant human luteinizing hormone (r-hLH) approved in the world. Luveris is available in the U.S. for concomitant use with Gonal-f (follitropin alfa for injection) to stimulate follicular development in profoundly LH-deficient hypogonadotropic hypogonadal (HH) women (LH < 1.2 IU/L). A definitive effect on pregnancy in this population has been demonstrated. The safety and effectiveness of concomitant administration of Luveris with any other preparation of recombinant human FSH or urinary human FSH is unknown.
|
Side Effects
Your healthcare professional should review the risks and benefits of using LuverisĀ® with you. As with any medication, report any and all side effects, symptoms or physical changes to your healthcare provider. Treatment with FSH and LH followed by human chorionic gonadotropin (hCG) can lead to a condition called ovarian hyperstimulation syndrome (OHSS). This condition can occur when the ovaries overreact to the treatment and become enlarged. A potential for the occurrence of blood clots in the blood vessels exists. Other conditions that can result from OHSS include blood volume changes or imbalances and extra fluid in the lungs or around the heart.
|
*All prices are subject to change without notice and prior to shipping.
|
|
|
 |
|
There are no items in your cart
|
|
 |
|
|
|
|
©2010 www.CanadaMedicineShop.com. All rights reserved.
Designed by www.orbitalmarketingsolutions.com.